However, we were consistent with Stevens et al., who recently suggested the bone marrow niche as an extra source for IL-6 in AML paediatric patients, where IL-6 acts on the blasts via its receptor to play a role in protecting blasts from the chemotherapy-induced apoptosis [7]. This evidence concerns the gene IL6 and acute myeloid leukemia.